Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Neuromodulation

Therapeutic area intelligence for Neuromodulation with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
5
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Nevro →
Pilot →

Recent signals(5)

ClinicalAugust 13, 2026

Pilot Study on Sacral Neuromodulation for Low Anterior Resection Syndrome Initiated

A pilot study is underway to evaluate early sacral neuromodulation in patients with Low Anterior Resection Syndrome, comparing it to standard conservative treatment.

ClinicalJuly 17, 2026

Study on taVNS for Postoperative Pain Management in Thoracoscopic Surgery

The study evaluates the efficacy and safety of transcutaneous auricular vagus nerve stimulation for managing postoperative pain.

ClinicalJuly 11, 2026

Study on Brain Stimulation's Impact on Food Intake and Weight Loss

This clinical trial investigates the effects of transcranial direct current stimulation (TDCS) on food intake and weight loss in obese individuals over four weeks.

ClinicalJuly 9, 2026

Study on rTMS for Methamphetamine Abuse in Methadone Patients Launched

A clinical trial is underway to evaluate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) for treating methamphetamine abuse in patients undergoing methadone maintenance therapy.

CompetitiveJune 28, 2026

Nevro's HF10 Therapy Study for Non-Surgical Refractory Back Pain Underway

Nevro Corp. is conducting a multi-center, randomized study to evaluate the safety and effectiveness of HF10 Therapy for chronic refractory back pain.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Obesity →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.